Siming Zhang1, Xianglong Zhang2, Carolin Purmann2, Shining Ma3, Anima Shrestha4, Kasey N Davis2, Marcus Ho2, Yiling Huang2, Reenal Pattni2, Wing Hung Wong3, Jonathan A Bernstein5, Joachim Hallmayer2, Alexander E Urban6. 1. Department of Genetics, School of Humanities and Science, Stanford University, Stanford, California. 2. Department of Psychiatry and Behavioral Sciences, School of Humanities and Science, Stanford University, Stanford, California. 3. and Department of Pediatrics, School of Humanities and Sciences, Stanford University, Stanford, California. 4. School of Medicine, Stanford University, and Department of Statistics, School of Humanities and Sciences, Stanford University, Stanford, California. 5. and Department of Human Biology, School of Humanities and Science, Stanford University, Stanford, California. 6. Department of Genetics, School of Humanities and Science, Stanford University, Stanford, California; Department of Psychiatry and Behavioral Sciences, School of Humanities and Science, Stanford University, Stanford, California. Electronic address: aeurban@stanford.edu.
Abstract
BACKGROUND: The 15q13.3 microdeletion is associated with several neuropsychiatric disorders, including autism and schizophrenia. Previous association and functional studies have investigated the potential role of several genes within the deletion in neuronal dysfunction, but the molecular effects of the deletion as a whole remain largely unknown. METHODS: Induced pluripotent stem cells, from 3 patients with the 15q13.3 microdeletion and 3 control subjects, were generated and converted into induced neurons. We analyzed the effects of the 15q13.3 microdeletion on genome-wide gene expression, DNA methylation, chromatin accessibility, and sensitivity to cisplatin-induced DNA damage. Furthermore, we measured gene expression changes in induced neurons with CRISPR (clustered regularly interspaced short palindromic repeats) knockouts of individual 15q13.3 microdeletion genes. RESULTS: In both induced pluripotent stem cells and induced neurons, gene copy number change within the 15q13.3 microdeletion was accompanied by significantly decreased gene expression and no compensatory changes in DNA methylation or chromatin accessibility, supporting the model that haploinsufficiency of genes within the deleted region drives the disorder. Furthermore, we observed global effects of the microdeletion on the transcriptome and epigenome, with disruptions in several neuropsychiatric disorder-associated pathways and gene families, including Wnt signaling, ribosome function, DNA binding, and clustered protocadherins. Individual gene knockouts mirrored many of the observed changes in an overlapping fashion between knockouts. CONCLUSIONS: Our multiomics analysis of the 15q13.3 microdeletion revealed downstream effects in pathways previously associated with neuropsychiatric disorders and indications of interactions between genes within the deletion. This molecular systems analysis can be applied to other chromosomal aberrations to further our etiological understanding of neuropsychiatric disorders.
BACKGROUND: The 15q13.3 microdeletion is associated with several neuropsychiatric disorders, including autism and schizophrenia. Previous association and functional studies have investigated the potential role of several genes within the deletion in neuronal dysfunction, but the molecular effects of the deletion as a whole remain largely unknown. METHODS: Induced pluripotent stem cells, from 3 patients with the 15q13.3 microdeletion and 3 control subjects, were generated and converted into induced neurons. We analyzed the effects of the 15q13.3 microdeletion on genome-wide gene expression, DNA methylation, chromatin accessibility, and sensitivity to cisplatin-induced DNA damage. Furthermore, we measured gene expression changes in induced neurons with CRISPR (clustered regularly interspaced short palindromic repeats) knockouts of individual 15q13.3 microdeletion genes. RESULTS: In both induced pluripotent stem cells and induced neurons, gene copy number change within the 15q13.3 microdeletion was accompanied by significantly decreased gene expression and no compensatory changes in DNA methylation or chromatin accessibility, supporting the model that haploinsufficiency of genes within the deleted region drives the disorder. Furthermore, we observed global effects of the microdeletion on the transcriptome and epigenome, with disruptions in several neuropsychiatric disorder-associated pathways and gene families, including Wnt signaling, ribosome function, DNA binding, and clustered protocadherins. Individual gene knockouts mirrored many of the observed changes in an overlapping fashion between knockouts. CONCLUSIONS: Our multiomics analysis of the 15q13.3 microdeletion revealed downstream effects in pathways previously associated with neuropsychiatric disorders and indications of interactions between genes within the deletion. This molecular systems analysis can be applied to other chromosomal aberrations to further our etiological understanding of neuropsychiatric disorders.
Authors: M Liu; S M Malone; U Vaidyanathan; M C Keller; G Abecasis; M McGue; W G Iacono; S I Vrieze Journal: Psychol Med Date: 2016-12-20 Impact factor: 7.723
Authors: Iuliana Ionita-Laza; Bin Xu; Vlad Makarov; Joseph D Buxbaum; J Louw Roos; Joseph A Gogos; Maria Karayiorgou Journal: Proc Natl Acad Sci U S A Date: 2013-12-16 Impact factor: 11.205
Authors: Jean-Baptiste Le Pichon; Shihui Yu; Nataliya Kibiryeva; William D Graf; Douglas C Bittel Journal: Eur J Hum Genet Date: 2013-01-30 Impact factor: 4.246
Authors: Vladimir Vacic; Shane McCarthy; Dheeraj Malhotra; Fiona Murray; Hsun-Hua Chou; Aine Peoples; Vladimir Makarov; Seungtai Yoon; Abhishek Bhandari; Roser Corominas; Lilia M Iakoucheva; Olga Krastoshevsky; Verena Krause; Verónica Larach-Walters; David K Welsh; David Craig; John R Kelsoe; Elliot S Gershon; Suzanne M Leal; Marie Dell Aquila; Derek W Morris; Michael Gill; Aiden Corvin; Paul A Insel; Jon McClellan; Mary-Claire King; Maria Karayiorgou; Deborah L Levy; Lynn E DeLisi; Jonathan Sebat Journal: Nature Date: 2011-02-23 Impact factor: 49.962
Authors: A Topol; J A English; E Flaherty; P Rajarajan; B J Hartley; S Gupta; F Desland; S Zhu; T Goff; L Friedman; J Rapoport; D Felsenfeld; G Cagney; A Mackay-Sim; J N Savas; B Aronow; G Fang; B Zhang; D Cotter; K J Brennand Journal: Transl Psychiatry Date: 2015-10-20 Impact factor: 6.222
Authors: Thanathom Chailangkarn; Cleber A Trujillo; Beatriz C Freitas; Branka Hrvoj-Mihic; Roberto H Herai; Diana X Yu; Timothy T Brown; Maria C Marchetto; Cedric Bardy; Lauren McHenry; Lisa Stefanacci; Anna Järvinen; Yvonne M Searcy; Michelle DeWitt; Wenny Wong; Philip Lai; M Colin Ard; Kari L Hanson; Sarah Romero; Bob Jacobs; Anders M Dale; Li Dai; Julie R Korenberg; Fred H Gage; Ursula Bellugi; Eric Halgren; Katerina Semendeferi; Alysson R Muotri Journal: Nature Date: 2016-08-10 Impact factor: 49.962
Authors: Frank Jühling; Helene Kretzmer; Stephan H Bernhart; Christian Otto; Peter F Stadler; Steve Hoffmann Journal: Genome Res Date: 2015-12-02 Impact factor: 9.043
Authors: Alena Kozlova; Siwei Zhang; Alex V Kotlar; Brendan Jamison; Hanwen Zhang; Serena Shi; Marc P Forrest; John McDaid; David J Cutler; Michael P Epstein; Michael E Zwick; Zhiping P Pang; Alan R Sanders; Stephen T Warren; Pablo V Gejman; Jennifer G Mulle; Jubao Duan Journal: Am J Hum Genet Date: 2022-08-04 Impact factor: 11.043
Authors: Marek B Körner; Akhil Velluva; Linnaeus Bundalian; Maximilian Radtke; Chen-Ching Lin; Pia Zacher; Tobias Bartolomaeus; Anna S Kirstein; Achmed Mrestani; Nicole Scholz; Konrad Platzer; Anne-Christin Teichmann; Julia Hentschel; Tobias Langenhan; Johannes R Lemke; Antje Garten; Rami Abou Jamra; Diana Le Duc Journal: Sci Rep Date: 2022-08-05 Impact factor: 4.996